Sushil Kumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sushil Kumar Singh has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Sarvesh Kumar
Department of Cardiovascular and Thoracic Surgery, King George’s Medical University, Lucknow, India
13 shared publications - Vivek Tewarson
Department of Cardiovascular and Thoracic Surgery, King George’s Medical University, Lucknow, India
11 shared publications Vivek Tewarson
Department of Cardiovascular and Thoracic Surgery, King George’s Medical University, Lucknow, Uttar Pradesh, India
7 shared publicationsSarvesh Kumar
Department of Cardiovascular and Thoracic Surgery, King George’s Medical University, Lucknow, Uttar Pradesh, India
6 shared publicationsVijayant Devenraj
King George’s Medical University
6 shared publicationsBhupendra Kumar
Department of Cardiovascular and Thoracic Surgery, King George’s Medical University, Lucknow, Uttar Pradesh, India
5 shared publications
Latest Publications
- Open Access
- 1 May 2025
- Published by Wolters Kluwer Health in Journal of Current Cardiology
- Vol. 3 (2) , 52-55
Artificial intelligence in healthcare management: A new paradigm shift, transforming the practice of cardiovascular medicine
In the ever-evolving landscape of modern health care, the integration of artificial intelligence (AI) has emerged as a transformative force with the potential to revolutionize patient care, diagnosis, and treatment. The applications of AI in health professions are broad and promising, offering innovative solutions to age-old challenges. AI is not one technology, but rather a collection of them. Cardiovascular disease (CVD) is a major threat to human health and the leading cause of death worldwide. The incidence of CVD caused 17.6 million deaths in 2016, an increase of 14.5% from 2006 to 2016. Unfortunately, the mortality and morbidity rates of CVD are increasing year by year, especially in developing regions. Studies have shown that approximately 80% of CVD-related deaths occur in low- and middle-income countries. Besides, these deaths occur at a younger age than in high-income countries. In developing countries, rapid economic transformation leads to environmental changes and unhealthy lifestyles; in addition, population aging may increase cardiovascular risk factors and increase the incidence of CVD. CVD has placed a heavy burden on patients and society as a whole. Therefore, it is necessary to provide strategies for improving the diagnosis and treatment of CVD in the future. Currently, AI may have the potential to solve this problem. However, it has been more than 60 years since the introduction of the concept of AI. The application of AI in medicine is still unclear. This article attempts to make a brief review of the current state of AI in cardiovascular medicine applications based on available information.
- 1 May 2025
- Published by Wolters Kluwer Health in Journal of Current Cardiology
- Vol. 3 (2) , 52-55
Open AccessArtificial intelligence in healthcare management: A new paradigm shift, transforming the practice of cardiovascular medicine
In the ever-evolving landscape of modern health care, the integration of artificial intelligence (AI) has emerged as a transformative force with the potential to revolutionize patient care, diagnosis, and treatment. The applications of AI in health professions are broad and promising, offering innovative solutions to age-old challenges. AI is not one technology, but rather a collection of them. Cardiovascular disease (CVD) is a major threat to human health and the leading cause of death worldwide. The incidence of CVD caused 17.6 million deaths in 2016, an increase of 14.5% from 2006 to 2016. Unfortunately, the mortality and morbidity rates of CVD are increasing year by year, especially in developing regions. Studies have shown that approximately 80% of CVD-related deaths occur in low- and middle-income countries. Besides, these deaths occur at a younger age than in high-income countries. In developing countries, rapid economic transformation leads to environmental changes and unhealthy lifestyles; in addition, population aging may increase cardiovascular risk factors and increase the incidence of CVD. CVD has placed a heavy burden on patients and society as a whole. Therefore, it is necessary to provide strategies for improving the diagnosis and treatment of CVD in the future. Currently, AI may have the potential to solve this problem. However, it has been more than 60 years since the introduction of the concept of AI. The application of AI in medicine is still unclear. This article attempts to make a brief review of the current state of AI in cardiovascular medicine applications based on available information.
- 24 December 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (7) , 915-918
Struck by Cupid’s arrow: penetrating chest trauma
Penetrating cardiac injuries are among the leading causes of immediate or early mortality following trauma, consequent to haemorrhage and acute trauma coagulopathy. A 50-year-old male presented 6 h following injury from structural collapse with stable vitals. He was impaled by an iron bar passing through his right hilum, entering the left atrium near the right superior pulmonary vein, and exiting through the right ventricle. Surgical removal of the rod was accomplished without cardiopulmonary bypass and minimal blood loss.
- 24 December 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (7) , 915-918
Struck by Cupid’s arrow: penetrating chest trauma
Penetrating cardiac injuries are among the leading causes of immediate or early mortality following trauma, consequent to haemorrhage and acute trauma coagulopathy. A 50-year-old male presented 6 h following injury from structural collapse with stable vitals. He was impaled by an iron bar passing through his right hilum, entering the left atrium near the right superior pulmonary vein, and exiting through the right ventricle. Surgical removal of the rod was accomplished without cardiopulmonary bypass and minimal blood loss.
- Open Access
- 1 January 2024
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 39 (5)
Early Mortality in Cardiac Surgery – Is Lactate Significant?
Serum lactate is a consequence of tissue hypoperfusion and has been used routinely for patient management following cardiac surgery. This study aims to determine the association of lactate with early mortality and postoperative morbidity. This is a prospective cohort study carried out in the Department of Cardiovascular and Thoracic Surgery, King George’s Medical University (India), from January 2020 to December 2022. A total of 270 patients were included in this study. Serum lactate levels were measured preoperatively, intraoperatively on-pump, coming off-pump, and at six, 12, 24, and 48 hours postoperatively. Early mortality was noted in 17 cases (6.3%). While both lactate and lactate clearance correlated with duration of mechanical ventilation, vasopressor duration, and intensive care unit and hospital stay, correlation with early mortality was noted only with lactate at 24 hours. Logistic regression analysis demonstrated that lactate levels at preoperative period (adjusted odds ratio [OR] 4.76 [1.67-13.59], P=0.004) and at 24 hours after bypass (OR 1.21 [1.00-1.47], P=0.046) and vasopressor duration (OR 1.11 [1.04-1.19], P=0.002) are independent predictors of mortality. Receiver operating characteristic curve analysis showed that arterial lactate on-pump, off-pump, and at six, 12, and 24 hours after surgery had significant area under the curve for predicting mortality. Arterial lactate and lactate clearance show good correlation with duration of mechanical ventilation, vasopressor support, and intensive care unit and hospital stay and can serve as a good indicator to guide therapeutic decisions in postoperative period. However, it fails to be a sensitive predictor of mortality.
- 1 January 2024
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 39 (5)
Open AccessEarly Mortality in Cardiac Surgery – Is Lactate Significant?
Serum lactate is a consequence of tissue hypoperfusion and has been used routinely for patient management following cardiac surgery. This study aims to determine the association of lactate with early mortality and postoperative morbidity. This is a prospective cohort study carried out in the Department of Cardiovascular and Thoracic Surgery, King George’s Medical University (India), from January 2020 to December 2022. A total of 270 patients were included in this study. Serum lactate levels were measured preoperatively, intraoperatively on-pump, coming off-pump, and at six, 12, 24, and 48 hours postoperatively. Early mortality was noted in 17 cases (6.3%). While both lactate and lactate clearance correlated with duration of mechanical ventilation, vasopressor duration, and intensive care unit and hospital stay, correlation with early mortality was noted only with lactate at 24 hours. Logistic regression analysis demonstrated that lactate levels at preoperative period (adjusted odds ratio [OR] 4.76 [1.67-13.59], P=0.004) and at 24 hours after bypass (OR 1.21 [1.00-1.47], P=0.046) and vasopressor duration (OR 1.11 [1.04-1.19], P=0.002) are independent predictors of mortality. Receiver operating characteristic curve analysis showed that arterial lactate on-pump, off-pump, and at six, 12, and 24 hours after surgery had significant area under the curve for predicting mortality. Arterial lactate and lactate clearance show good correlation with duration of mechanical ventilation, vasopressor support, and intensive care unit and hospital stay and can serve as a good indicator to guide therapeutic decisions in postoperative period. However, it fails to be a sensitive predictor of mortality.
- 8 November 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (1) , 99-102
Isolated cardiac cysticercosis of the right ventricle
Cardiac cysticercosis is a rarely encountered form of cysticercosis, caused by the larval cyst of tapeworm (Taenia solium). It commonly affects the central nervous system; however, systematic involvement has been reported as well. We describe a case of isolated cardiac cysticercosis incidentally discovered in a 16-year-old female undergoing surgical closure of a ventricular septal defect (VSD), with no prior history of parasitic infestation. Our objective is to highlight the importance of cardiac cysticercosis as a differential finding in epicardial cystic masses which may be missed or misinterpreted on imagining modalities and to the limited literature on this particular rate manifestation of cysticercosis.
- 8 November 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (1) , 99-102
Isolated cardiac cysticercosis of the right ventricle
Cardiac cysticercosis is a rarely encountered form of cysticercosis, caused by the larval cyst of tapeworm (Taenia solium). It commonly affects the central nervous system; however, systematic involvement has been reported as well. We describe a case of isolated cardiac cysticercosis incidentally discovered in a 16-year-old female undergoing surgical closure of a ventricular septal defect (VSD), with no prior history of parasitic infestation. Our objective is to highlight the importance of cardiac cysticercosis as a differential finding in epicardial cystic masses which may be missed or misinterpreted on imagining modalities and to the limited literature on this particular rate manifestation of cysticercosis.
- Open Access
- 1 May 2023
- Published by Medknow in Journal of the Practice of Cardiovascular Sciences
- Vol. 9 (2) , 155-157
A Simple and Innovative Repair of an Incidentally Discovered Sinus of Valsalva Aneurysm during Aortic Valve Replacement
The sinus of Valsalva aneurysm is a rare pathological lesion found in around 0.09% of the population. Surgical management is usually indicated for large aneurysms causing hemodynamic compromise or aneurysms that enlarge progressively. Surgical approaches for unruptured aneurysms include patch or primary closure. The article describes our technique for closing the small sinus of a Valsalva aneurysm discovered incidentally during surgery for aortic valve replacement. Interrupted pledgeted sutures placed for fixing the mechanical prosthetic aortic valve (St Judes Medical TM) were passed through the aortic valve annulus and the superior edge of the aneurysm sac, resulting in transverse primary closure of the aneurysm opening in the aortic root.
- 1 May 2023
- Published by Medknow in Journal of the Practice of Cardiovascular Sciences
- Vol. 9 (2) , 155-157
Open AccessA Simple and Innovative Repair of an Incidentally Discovered Sinus of Valsalva Aneurysm during Aortic Valve Replacement
The sinus of Valsalva aneurysm is a rare pathological lesion found in around 0.09% of the population. Surgical management is usually indicated for large aneurysms causing hemodynamic compromise or aneurysms that enlarge progressively. Surgical approaches for unruptured aneurysms include patch or primary closure. The article describes our technique for closing the small sinus of a Valsalva aneurysm discovered incidentally during surgery for aortic valve replacement. Interrupted pledgeted sutures placed for fixing the mechanical prosthetic aortic valve (St Judes Medical TM) were passed through the aortic valve annulus and the superior edge of the aneurysm sac, resulting in transverse primary closure of the aneurysm opening in the aortic root.
- 10 February 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (3) , 300-304
Cardiac synovial sarcoma masquerading as effusive constrictive pericarditis
Primary cardiac synovial sarcoma is a rare entity, arising from the pericardium or the chambers of the heart. It presents in the 4th decade of life with a striking male predisposition. We describe an unusual case of a 22-year-old female who presented with complaints of dyspnoea on exertion, palpitations, and chest pain. Trans-thoracic echocardiography was suggestive of a cystic pericardial mass with pericardial effusion anterior and lateral to the right ventricle. Computed tomography scan (CT scan) revealed thick-walled predominantly cystic lesion over the left ventricle with gross pericardial effusion with internal septations. These findings were suggestive of an infected pericardial cyst. Upon surgery, an adherent mass in the pericardial cavity was found which was not separable from the right heart structures, the great vessels, and the left ventricle. Biopsy was taken, histopathology was suggestive of spindle cell neoplasm, and an immunohistochemistry analysis revealed Transducin-like enhancer of split 1 (TLE 1)–positive malignant spindle cell tumour likely synovial sarcoma. After surgery, the patient received serial adjuvant chemo-radiation therapy. The synovial sarcoma masqueraded as effusive constrictive pericarditis, due to which it eluded preoperative diagnosis.
- 10 February 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (3) , 300-304
Cardiac synovial sarcoma masquerading as effusive constrictive pericarditis
Primary cardiac synovial sarcoma is a rare entity, arising from the pericardium or the chambers of the heart. It presents in the 4th decade of life with a striking male predisposition. We describe an unusual case of a 22-year-old female who presented with complaints of dyspnoea on exertion, palpitations, and chest pain. Trans-thoracic echocardiography was suggestive of a cystic pericardial mass with pericardial effusion anterior and lateral to the right ventricle. Computed tomography scan (CT scan) revealed thick-walled predominantly cystic lesion over the left ventricle with gross pericardial effusion with internal septations. These findings were suggestive of an infected pericardial cyst. Upon surgery, an adherent mass in the pericardial cavity was found which was not separable from the right heart structures, the great vessels, and the left ventricle. Biopsy was taken, histopathology was suggestive of spindle cell neoplasm, and an immunohistochemistry analysis revealed Transducin-like enhancer of split 1 (TLE 1)–positive malignant spindle cell tumour likely synovial sarcoma. After surgery, the patient received serial adjuvant chemo-radiation therapy. The synovial sarcoma masqueraded as effusive constrictive pericarditis, due to which it eluded preoperative diagnosis.
- Open Access
- 1 January 2023
- Published by Medknow in Research in Cardiovascular Medicine
- Vol. 12 (1) , 39-41
Emergent Surgical Retrieval of an Embolized Atrial Septal Occluder Device from Right Ventricle – An Unusual Occurrence
Atrial septal defect (ASD) is one of the most common congenital heart defects (3.78/10,000 live births). For several decades, surgical closure has been considered the standard method of repairing an ostium secundum ASD. Surgical treatment is safe and effective, but the complications relate to bleeding, arrhythmia, and residual defects. However, over the years, percutaneous device closure using the Amplatzer ASD occluder (AGA Medical Corp., Golden Valley, Minnesota) has been widely used for the treatment of ASD and has proven to be effective and safe as traditional surgical repair. However, procedure- or device-related complications can occur; Complications commonly associated with ASD closure device includes residual shunt, device malposition or embolization, thrombosis in the vena cava or atrium and erosion of the surrounding tissue which may lead to perforation of the heart, which could be fatal. We report an unusual case of a 16-year-old female with embolization of the ASD occluder device into the right ventricle immediately after device deployment. We removed the device surgically and closed the ASD in a standard manner, with an autologous pericardial patch. The patient was discharged from the hospital without any complications.
- 1 January 2023
- Published by Medknow in Research in Cardiovascular Medicine
- Vol. 12 (1) , 39-41
Open AccessEmergent Surgical Retrieval of an Embolized Atrial Septal Occluder Device from Right Ventricle – An Unusual Occurrence
Atrial septal defect (ASD) is one of the most common congenital heart defects (3.78/10,000 live births). For several decades, surgical closure has been considered the standard method of repairing an ostium secundum ASD. Surgical treatment is safe and effective, but the complications relate to bleeding, arrhythmia, and residual defects. However, over the years, percutaneous device closure using the Amplatzer ASD occluder (AGA Medical Corp., Golden Valley, Minnesota) has been widely used for the treatment of ASD and has proven to be effective and safe as traditional surgical repair. However, procedure- or device-related complications can occur; Complications commonly associated with ASD closure device includes residual shunt, device malposition or embolization, thrombosis in the vena cava or atrium and erosion of the surrounding tissue which may lead to perforation of the heart, which could be fatal. We report an unusual case of a 16-year-old female with embolization of the ASD occluder device into the right ventricle immediately after device deployment. We removed the device surgically and closed the ASD in a standard manner, with an autologous pericardial patch. The patient was discharged from the hospital without any complications.
- 16 June 2022
- Published by Jaypee Brothers Medical Publishing in The Indian Journal of Chest Diseases and Allied Sciences
- Vol. 54 (3) , 201-203
Calcified Left Atrial Myxoma with Osseous Metaplasia
An intracardiac myxoma is the most common tumour of the heart with an estimated incidence of 0.5 per million population per year. Extensive calcification is rare in these tumours. We describe a rare case of a large left atrial myxoma, visible on the chest radiograph, with extensive calcification and osseous metaplasia.
- 16 June 2022
- Published by Jaypee Brothers Medical Publishing in The Indian Journal of Chest Diseases and Allied Sciences
- Vol. 54 (3) , 201-203
Calcified Left Atrial Myxoma with Osseous Metaplasia
An intracardiac myxoma is the most common tumour of the heart with an estimated incidence of 0.5 per million population per year. Extensive calcification is rare in these tumours. We describe a rare case of a large left atrial myxoma, visible on the chest radiograph, with extensive calcification and osseous metaplasia.
- 1 October 2021
- Published by Medknow in Journal of Arthroscopy and Joint Surgery
- Vol. 8 (4) , 346-349
Efficacy of topical versus intravenous tranexamic acid in bilateral total knee arthroplasty
- 1 October 2021
- Published by Medknow in Journal of Arthroscopy and Joint Surgery
- Vol. 8 (4) , 346-349
Efficacy of topical versus intravenous tranexamic acid in bilateral total knee arthroplasty
- Open Access
- 1 January 2021
- Published by Medknow in Heart India
- Vol. 9 (1) , 35-39
Delayed perforation of the right ventricle by pacemaker/automated implantable cardioverter-defibrillator lead
Introduction: Cardiac perforation by pacemaker/automatic implantable cardioverter-defibrillator (AICD) lead can be a life-threatening emergency. Delayed cardiac perforation by pacemaker/AICD lead is defined as perforation occurring after a period of 1 month following pacemaker/AICD insertion. Delayed perforation is often difficult to identify at first and needs active intervention to prevent complications and death. Materials and Methods: Patients presenting with and operated upon for delayed cardiac perforation following pacemaker/AICD insertion were included in this study. The study was conducted between April 2019 and April 2020. Results: Three patients reported with delayed cardiac perforation after pacemaker insertion. All patients had syncopal episodes, and detection could be easily done using chest X-ray and trans-thoracic echocardiography (TTE). Two patients had active fixation leads used for anchoring the lead in the right ventricle (RV). Two patients were female, while one was a male, and all had perforation through the RV apex. Lead reposition was done in two cases, thereby preventing the need for placing additional leads, while a new lead was required in the third case. Conclusion: Early identification of cardiac perforation can be done easily with chest X-ray and TTE, but a high index of suspicion should be kept in mind. Surgical or fluoroscopic intervention may be planned depending on the available expertise and patient condition.
- 1 January 2021
- Published by Medknow in Heart India
- Vol. 9 (1) , 35-39
Open AccessDelayed perforation of the right ventricle by pacemaker/automated implantable cardioverter-defibrillator lead
Introduction: Cardiac perforation by pacemaker/automatic implantable cardioverter-defibrillator (AICD) lead can be a life-threatening emergency. Delayed cardiac perforation by pacemaker/AICD lead is defined as perforation occurring after a period of 1 month following pacemaker/AICD insertion. Delayed perforation is often difficult to identify at first and needs active intervention to prevent complications and death. Materials and Methods: Patients presenting with and operated upon for delayed cardiac perforation following pacemaker/AICD insertion were included in this study. The study was conducted between April 2019 and April 2020. Results: Three patients reported with delayed cardiac perforation after pacemaker insertion. All patients had syncopal episodes, and detection could be easily done using chest X-ray and trans-thoracic echocardiography (TTE). Two patients had active fixation leads used for anchoring the lead in the right ventricle (RV). Two patients were female, while one was a male, and all had perforation through the RV apex. Lead reposition was done in two cases, thereby preventing the need for placing additional leads, while a new lead was required in the third case. Conclusion: Early identification of cardiac perforation can be done easily with chest X-ray and TTE, but a high index of suspicion should be kept in mind. Surgical or fluoroscopic intervention may be planned depending on the available expertise and patient condition.